TRAIL, aa261-277, Blocking Peptide (TNF-Related Apoptosis Inducing Ligand, Apo2L, TL2, TNFSF10)

Catalog Number: USB-T8175P
Article Name: TRAIL, aa261-277, Blocking Peptide (TNF-Related Apoptosis Inducing Ligand, Apo2L, TL2, TNFSF10)
Biozol Catalog Number: USB-T8175P
Supplier Catalog Number: T8175P
Alternative Catalog Number: USB-T8175P-50
Manufacturer: US Biological
Category: Molekularbiologie
Peptide corresponding to amino acid 261 to 277 of human TRAIL. Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors, TNFR1 and Fas. A novel member in the TNF family was recently identified and designated TRAIL (for TNF-related apoptosis-inducing ligand) and Apo-2L (for Apo-2 ligand)1,2. TRAIL is a type II membrane protein and expressed in a variety of human tissues. Two novel death domain containing receptors DR4 and DR5 have been identified as the receptor for TRAIL3-6. Like TNF and Fas ligand, TRAIL induces apoptosis and NF-kB activation in many tissues and cells.
NCBI: 003801
Purity: Purified
Form: Supplied as a liquid in PBS, pH 7.2, 0.1% BSA, 0.02% sodium azide.